277 related articles for article (PubMed ID: 25807114)
1. Pharmacokinetics and immunogenicity of broadly neutralizing HIV monoclonal antibodies in macaques.
Rosenberg Y; Sack M; Montefiori D; Labranche C; Lewis M; Urban L; Mao L; Fischer R; Jiang X
PLoS One; 2015; 10(3):e0120451. PubMed ID: 25807114
[TBL] [Abstract][Full Text] [Related]
2. Introduction of the YTE mutation into the non-immunogenic HIV bnAb PGT121 induces anti-drug antibodies in macaques.
Rosenberg YJ; Lewis GK; Montefiori DC; LaBranche CC; Lewis MG; Urban LA; Lees JP; Mao L; Jiang X
PLoS One; 2019; 14(2):e0212649. PubMed ID: 30785963
[TBL] [Abstract][Full Text] [Related]
3. Protective Efficacy of Broadly Neutralizing Antibodies with Incomplete Neutralization Activity against Simian-Human Immunodeficiency Virus in Rhesus Monkeys.
Julg B; Sok D; Schmidt SD; Abbink P; Newman RM; Broge T; Linde C; Nkolola J; Le K; Su D; Torabi J; Pack M; Pegu A; Allen TM; Mascola JR; Burton DR; Barouch DH
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768869
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 maternal and infant variants show similar sensitivity to broadly neutralizing antibodies, but sensitivity varies by subtype.
Mabuka J; Goo L; Omenda MM; Nduati R; Overbaugh J
AIDS; 2013 Jun; 27(10):1535-44. PubMed ID: 23856624
[TBL] [Abstract][Full Text] [Related]
5. Development of Broadly Neutralizing Antibodies and Their Mapping by Monomeric gp120 in Human Immunodeficiency Virus Type 1-Infected Humans and Simian-Human Immunodeficiency Virus SHIVSF162P3N-Infected Macaques.
Jia M; Lu H; Markowitz M; Cheng-Mayer C; Wu X
J Virol; 2016 Apr; 90(8):4017-4031. PubMed ID: 26842476
[TBL] [Abstract][Full Text] [Related]
6. Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.
Cohen YZ; Lorenzi JCC; Seaman MS; Nogueira L; Schoofs T; Krassnig L; Butler A; Millard K; Fitzsimons T; Daniell X; Dizon JP; Shimeliovich I; Montefiori DC; Caskey M; Nussenzweig MC
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237833
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity to Broadly Neutralizing Antibodies of Recently Transmitted HIV-1 Clade CRF02_AG Viruses with a Focus on Evolution over Time.
Stefic K; Bouvin-Pley M; Essat A; Visdeloup C; Moreau A; Goujard C; Chaix ML; Braibant M; Meyer L; Barin F
J Virol; 2019 Jan; 93(2):. PubMed ID: 30404804
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Ability of Plant-Derived PGT121 Glycovariants To Eliminate HIV-1-Infected Cells.
Anand SP; Ding S; Tolbert WD; Prévost J; Richard J; Gil HM; Gendron-Lepage G; Cheung WF; Wang H; Pastora R; Saxena H; Wakarchuk W; Medjahed H; Wines BD; Hogarth M; Shaw GM; Martin MA; Burton DR; Hangartner L; Evans DT; Pazgier M; Cossar D; McLean MD; Finzi A
J Virol; 2021 Aug; 95(18):e0079621. PubMed ID: 34232070
[TBL] [Abstract][Full Text] [Related]
9. V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1.
Morgand M; Bouvin-Pley M; Plantier JC; Moreau A; Alessandri E; Simon F; Pace CS; Pancera M; Ho DD; Poignard P; Bjorkman PJ; Mouquet H; Nussenzweig MC; Kwong PD; Baty D; Chames P; Braibant M; Barin F
J Acquir Immune Defic Syndr; 2016 Mar; 71(3):237-45. PubMed ID: 26413851
[TBL] [Abstract][Full Text] [Related]
10. Rapid high-level production of functional HIV broadly neutralizing monoclonal antibodies in transient plant expression systems.
Rosenberg Y; Sack M; Montefiori D; Forthal D; Mao L; Hernandez-Abanto S; Urban L; Landucci G; Fischer R; Jiang X
PLoS One; 2013; 8(3):e58724. PubMed ID: 23533588
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies.
Wang H; Yuan T; Li T; Li Y; Qian F; Zhu C; Liang S; Hoffmann D; Dittmer U; Sun B; Yang R
Arch Virol; 2018 Dec; 163(12):3303-3315. PubMed ID: 30196320
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Cross-Clade Characterization of Antibody-Mediated Recognition, Complement-Mediated Lysis, and Cell-Mediated Cytotoxicity of HIV-1 Envelope-Specific Antibodies toward Eradication of the HIV-1 Reservoir.
Mujib S; Liu J; Rahman AKMN; Schwartz JA; Bonner P; Yue FY; Ostrowski MA
J Virol; 2017 Aug; 91(16):. PubMed ID: 28592534
[TBL] [Abstract][Full Text] [Related]
13. Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies.
Otsuka Y; Schmitt K; Quinlan BD; Gardner MR; Alfant B; Reich A; Farzan M; Choe H
PLoS Pathog; 2018 Aug; 14(8):e1007238. PubMed ID: 30125330
[TBL] [Abstract][Full Text] [Related]
14. Anti-drug Antibody Responses Impair Prophylaxis Mediated by AAV-Delivered HIV-1 Broadly Neutralizing Antibodies.
Gardner MR; Fetzer I; Kattenhorn LM; Davis-Gardner ME; Zhou AS; Alfant B; Weber JA; Kondur HR; Martinez-Navio JM; Fuchs SP; Desrosiers RC; Gao G; Lifson JD; Farzan M
Mol Ther; 2019 Mar; 27(3):650-660. PubMed ID: 30704961
[TBL] [Abstract][Full Text] [Related]
15. Protection against SHIV Challenge by Subcutaneous Administration of the Plant-Derived PGT121 Broadly Neutralizing Antibody in Macaques.
Rosenberg YJ; Montefiori DC; LaBranche CC; Lewis MG; Sack M; Lees JP; Jiang X
PLoS One; 2016; 11(3):e0152760. PubMed ID: 27031108
[TBL] [Abstract][Full Text] [Related]
16. A single mutation turns a non-binding germline-like predecessor of broadly neutralizing antibody into a binding antibody to HIV-1 envelope glycoproteins.
Yuan T; Li J; Zhang MY
MAbs; 2011; 3(4):402-7. PubMed ID: 21540646
[TBL] [Abstract][Full Text] [Related]
17. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
18. Of Mice, Macaques, and Men: Broadly Neutralizing Antibody Immunotherapy for HIV-1.
Nishimura Y; Martin MA
Cell Host Microbe; 2017 Aug; 22(2):207-216. PubMed ID: 28799906
[TBL] [Abstract][Full Text] [Related]
19. Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection.
Saunders KO; Wang L; Joyce MG; Yang ZY; Balazs AB; Cheng C; Ko SY; Kong WP; Rudicell RS; Georgiev IS; Duan L; Foulds KE; Donaldson M; Xu L; Schmidt SD; Todd JP; Baltimore D; Roederer M; Haase AT; Kwong PD; Rao SS; Mascola JR; Nabel GJ
J Virol; 2015 Aug; 89(16):8334-45. PubMed ID: 26041300
[TBL] [Abstract][Full Text] [Related]
20. Broadly Neutralizing Antibodies Display Potential for Prevention of HIV-1 Infection of Mucosal Tissue Superior to That of Nonneutralizing Antibodies.
Cheeseman HM; Olejniczak NJ; Rogers PM; Evans AB; King DFL; Ziprin P; Liao HX; Haynes BF; Shattock RJ
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
